Thursday, October 22, 2015

FDA Warns on AbbVie's Hepatitis C Treatments

The U.S. Food and Drug Administration warned Thursday that AbbVie Inc.’s hepatitis C treatments Viekira Pak and Technivie could cause serious liver harm among patients with underlying liver disease.

from WSJ.com: US Business http://ift.tt/1LITV0h
via IFTTT

No comments:

Post a Comment